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Abstract
Background: Indicators of quality of care for children in hospitals in low-income countries have been proposed,
but information on their perceived validity and acceptability is lacking.
Methods: Potential indicators representing structural and process aspects of care for six common conditions were
selected from existing, largely qualitative WHO assessment tools and guidelines. We employed the Delphi
technique, which combines expert opinion and existing scientific information, to assess their perceived validity and
acceptability. Panels of experts, one representing an international panel and one a national (Kenyan) panel, were
asked to rate the indicators over 3 rounds and 2 rounds respectively according to a variety of attributes.
Results: Based on a pre-specified consensus criteria most of the indicators presented to the experts were accepted:
112/137(82%) and 94/133(71%) for the international and local panels respectively. For the other indicators there
was no consensus; none were rejected. Most indicators were rated highly on link to outcomes, reliability, relevance,
actionability and priority but rated more poorly on feasibility of data collection under routine conditions. There was
moderate to substantial agreement between the two panels of experts.
Conclusions: This Delphi study provided evidence for the perceived usefulness of most of a set of measures of
quality of hospital care for children proposed for use in low-income countries. However, both international and
local experts expressed concerns that data for many process-based indicators may not currently be available. The
feasibility of widespread quality assessment and responsiveness of indicators to intervention should be examined
as part of continued efforts to improve approaches to informative hospital quality assessment.
Background
Delivery of good quality health care has considerable
potential to reduce childhood deaths in low-income
countries where mortality is high [1,2]. However, both
anecdotal and empirical evidence suggest that the qual-
ity of care offered in many facilities, both primary and
referral, is generally poor [3-8]. Valid and reliable per-
formance measures (indicators) can be used to evaluate
quality of care and help health workers to improve it
[9]. In some high income countries, quality of care mea-
sures are increasingly recognized as a priority to help
foster improvement and promote accountability, and
substantial investments have been made in their devel-
opment [10-12]. In contrast, relatively little effort has
been put into developing such measures for low-income
countries [13].
Recently, the WHO revised an earlier tool for asses-
sing the quality of care in first-referral health care facil-
ities (rural or district level hospitals) in developing
countries, based on multi-country experience and
informed by discussions at a global WHO meeting in
Bali in 2007 [14]. The WHO tool is based on the classi-
cal quality of care framework involving structure, pro-
cess and outcome [15]. Amendments can be made to
this tool by countries to suit their local needs. Uptake of
the tool will probably depend on “buy in” and support
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from influential persons in each country. Using this tool,
structure and processes of care are rated on a simple
semi-qualitative scale (the latter based on a convenience
sample of 5 cases) making it useful for rapid appraisal of
hospitals. However, such scores are of limited value if
the aim is to provide an objective comparison between
hospitals within a region or within hospitals at different
periods - particularly if different observers use the tool.
The debate about which quality measures are best
continues [16]. Proponents of process measures argue
that they directly measure actions that are within the
control of health workers [17]. However, without appro-
priate drugs and equipment, health workers may be
unable to offer the correct care, making structure a lim-
iting factor in quality improvement [18]. Outcome mea-
sures may be intuitively the most useful indicators of
quality, but their opponents argue that they are subject
to considerable confounding and may require large sam-
ples for sufficiently precise measurement.
To decide which measures to use, expert judgement,
supported by evidence where available, is often used.
Experts, however, differ in opinion and a family of con-
sensus methods such as the nominal group technique
(NGT), the Delphi technique, and the RAND/UCLA
appropriateness method (a hybrid of the former two),
are often used to facilitate communication and avoid the
negative social influences associated with group pro-
cesses [19]. This article reports the results of a Delphi
study that aimed to determine which measures of qual-
ity of admission care for children in first level referral
hospitals in low-income countries were widely sup-
ported, using explicit methods. Performance measures
can be used to assess quality at different levels - clinical,
organisation or population. This study considered mea-
sures pertinent to the clinical level. Further, the study
aimed to identify process measures which could give
quantitative measures of performance and performance
change. We had a particular focus on the African setting
and also examined the likely acceptability of internation-
ally suggested indicators to an influential Kenyan audi-
ence. Ethical approval was obtained from the KEMRI
National Ethical Review Committee.
Methods
Panel selection
It is recommended that expert panels be multidisciplin-
ary and inclusive of individuals from geographically
diverse and culturally disparate areas [20,21]. This het-
erogeneity is thought to bring a wealth of experience
and knowledge, and enhance the richness of the discus-
sion. In the current study, two panels of experts were
set up. Panel one, the International Panel, consisted of
participants predominantly drawn from the 2007 WHO
conference on quality of care for children, and members
of an informal WHO-linked Paediatric Quality-of-Care
email discussion group. Many have published work on
quality of care in low-income settings [14]. Panel two,
the national panel, consisted of faculty from the Paedia-
tric Department of the University of Nairobi and senior
policy-makers in the Kenyan Ministry of Health. The
characteristics of the experts are presented in Additional
file 1.
Establishing the scope
Six common childhood topics were chosen for indicator
development: malaria, pneumonia, diarrhoea, meningitis,
malnutrition, and problems of the sick newborn. These
conditions account for over 80% of morbidity and mor-
tality in hospitals in low-income countries in Africa
[22], including Kenya [23]. It has been shown that the
care provided for these conditions often varies consider-
ably and is of poor quality [3,6,8,24-27]. However, there
are affordable and effective treatments for these condi-
tions, defined by international guidelines promoted by
the WHO/UNICEF and, in Kenya, by the government
[28,29]. These provide a useful quality standard.
From the generic WHO Hospital assessment tool and
the associated international [14], evidence-based guide-
lines [28], researchers (SN, ME) developed a list of
potential indicators. The indicators were equally distrib-
uted between those based on structure and those based
on process of care. The number of process indicators
considered for each condition (e.g. pneumonia, malaria
etc) was similar. Outcome measures were not consid-
ered for the reasons alluded to above.
A questionnaire was then developed based on the cho-
sen indicators. For all potential indicators the panelists
were asked, drawing from their experience, to rate the
indicators on various attributes (Figure 1) on a 9 point
Likert-type scale ranging from 1 (strongly disagree) to
9 (strongly agree) [30].
Some indicators were composites combining several
stage-specific individual indicators. Experts were asked
to indicate whether they preferred the composites to the
individual constituent indicators. Experts were also
asked to indicate in how many areas of the hospital pro-
viding paediatric or newborn care a specific item (e.g. a
drug or piece of equipment) ought to be present before
the item was considered, in aggregate, available at a hos-
pital level.
The limited evidence suggests that better results can be
achieved if the participants are given reviews of the litera-
ture [30,31]. We did not do this because summarising the
evidence would have been an unrealistically large task
given the range of topics considered. Moreover, experi-
ence suggests that in fact there is often very little high
quality evidence for commonly accepted best practices
[32]. Instead the experts were provided with both a link
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to the WHO guidelines for hospital care [28] and to a
web-based resource where evidence behind the WHO
guidance is progressively being archived http://www.ichrc.
org.
International/WHO expert panel process
The international panel completed three rounds of ques-
tionnaires. The first questionnaire was sent in May
2008. This was accompanied by a covering letter giving
information about the Delphi process such as the antici-
pated time required to complete the first questionnaire,
how to contact the researchers in case of queries and
the deadline for completing the round. In this first
round, indicators were rated on only four attributes: link
to outcome, reliability, relevance and actionability.
Explanations of the attributes were given to the experts
and are shown in Figure 1. In addition, experts were
asked to suggest new indicators.
In the second round all the experts were provided
with their own responses for each indicator and attri-
bute, and the corresponding panel median responses
from the first iteration. They were also provided with a
summary of the written comments made in the first
round complied by one of the investigators (ME) acting
as a moderator. Experts were asked to reflect on the
feedback and re-rate each item in light of this informa-
tion. In a few instances, indicator statements were
reworded because they were noted by the experts to be
ambiguous on the first round. Additional indicators
were included following suggestions made in the first
round. Two additional attributes were also introduced:
i) priority for reporting the indicator to the Ministry of
Health and, ii) feasibility of data collection (Figure 1).
Opinions on feasibility were requested for process-based
indicators only as feasibility of indicator assessment was
not considered to be an issue with structural elements -
their presence or absence can easily be ascertained. We
hoped that these additional attributes, together with the
comments from the moderator, would assist the experts
to decide which indicators could (feasibility) and should
(priority) be included in routine quality assessment. A
third round for this panel was conducted similarly.
Reminders were regularly sent to the experts (range, 1-
4 reminders) and the process was completed in Septem-
ber 2008.
National panel process
The local panel of experts completed two rounds of the
questionnaire. The experts were invited to the research-
ers’ organization (KEMRI) in June 2008 and the study
explained in a Microsoft PowerPoint® presentation. Then
the experts completed the questionnaire in private. The
international panel Round 2 questionnaire served as the
first round for the national panel. The aggregated scores
and summary of results from the WHO panel were how-
ever not included. The second round was completed 2
weeks later at the same venue, with experts again filling
in the questionnaire in private. The questionnaire pro-
vided in this round presented the expert’s own score and
the indicator specific median response of the local panel.
Experts were asked to consider revising their previous
views in light of this information and the criterion of
priority to the Ministry of Health was emphasised. The
local expert opinion was used to assess the degree to
which recommendations made by an international panel
are endorsed in our local setting.
Analysis
Median scores and frequency of responses in each tertile
Likert category (1-3, 4-6, and 7-9) were calculated. We
defined an indicator as being accepted with agreement
according to the following pre-specified criteria (consen-
sus criterion 1) [33]:-
• An indicator was accepted with agreement if two
thirds or more of the experts rated the indicator in
the upper tertile (7-9) on link to outcomes and a
score of 4 or more on reliability, relevance and
actionability.
• An indicator was rejected with agreement if two
thirds or more of the experts rated the indicator in
the lowest tertile (1-3) on link to outcomes.
• An indicator was classified as uncertain/equivocal
if they did not fall in either of the above groups.
A second post hoc definition of indicator acceptance
and agreement, using the same thresholds as above (for
Figure 1 Definitions of attributes used to rate the indicators.
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consensus criterion 1), but with the further requirement
of ‘good’ agreement about the link to outcomes, defined
as an inter-quartile range on the link to outcomes attri-
bute not exceeding two (consensus criterion 2). This lat-
ter definition captures the fact that consensus within a
group is reflected in smaller variance (smaller IQR) of
the responses.
An indicator was defined as a priority for reporting,
feasible currently or feasible with improvement if its
median score for these specific attribute was 7 or more
(consensus criterion 3). A post hoc consensus criterion 4
was defined as criterion 3 plus an IQR of less than 2 for
these attributes. Finally the process indicators were
ranked by ordering them (highest to lowest) using
scores achieved on attributes using the following
sequence: feasibility with current data, feasibility with
improvement of data collection methods and priority for
reporting. An indicator was ranked highly if it had high
median score on these attributes with a narrow IQR on
these attributes. The structure indicators were ranked
by priority only. The Wilcoxon signed-rank test was
used to test differences in ranking between the two
panels. Consensus on the number of places in a hospital
where an item must be present to define availability in
aggregate was based on a simple majority view (more
than 50%) of the experts.
Three-way kappa was used to evaluate reliability of
views for the three levels of agreement: accepted, equi-
vocal and rejected. The responses according to consen-
sus criterion 1 from each panel from the final round
were treated as responses from two raters for these ana-
lyses. The confidence intervals for kappa were obtained
using bootstrap methods with 5000 replications. These
analyses were carried out in Stata® version 10.2 (Stata-
Corp, Texas, USA) using the kapci command and with
Stata’s pre-recorded weight, w, in measuring the impor-
tance of disagreements [34]. The kappa values represent
the proportionate agreement adjusted for chance and
range from 0 (no agreement beyond chance) to 1 (per-
fect agreement).
Results
Responses
Forty percent of those invited to the international panel
declined the offer, citing reasons including lack of time
and insufficient experience of the topic. 10% and 24 %
of the international experts returning round 1 did not
complete rounds 2 and 3 respectively. 16/19 of the local
experts invited to participate in the process accepted the
offer and all but one completed the process.
Indicator ratings
The international experts rated 114 indictors in the first
round. A further 23 indicators suggested by them were
incorporated and rated in the second round. All 137
indicators were rated in the third round. The local panel
rated 133 indicators in both rounds, 132 of which were
the same as for the international and local panel (Figure
2). Some indicators suggested by the international panel
were not included in the local panel questionnaire and
one indicator on HIV was added to the latter’s question-
naire after discussion with local policy makers.
Most indicators were highly rated (median score ≥7)
by both panels on the various attributes except on ‘feasi-
bility at present’, ‘feasibility with improvement’ and
‘priority’ (depicted on Figure 3 and further described in
Additional file 2). Opinions on what indicators were
considered a priority varied more widely (large IQR),
particularly within the local panel and for structure indi-
cators. For simplicity and ease of comparison, we con-
sider here only those indicators that were rated by both
panels.
The patterns of ratings for each panel were similar
between the rounds with only minor changes according
to consensus criterion 1 (Table 1). However, the number
of indicators accepted in the final round using consen-
sus criterion 2 increased by 79% from the previous
round for the international panel but fell by 36% for the
local panel, indicating a convergence of views in the
final round for the international panel and a divergence
of views for the local panel. Conclusions are based on
the respective final round ratings which are presented
henceforth.
Based on our pre-specified criteria the majority of the
indicators (111/132(84.0%)) and 93/132(70.5%) for inter-
national and local panels respectively) presented to the
experts were accepted. For no indicator was there a con-
sensus for rejection. About a half of those accepted were
Figure 2 Procedural flow chart showing the development of
quality indicators using the Delphi technique. n denotes the
number of indicators rated in the round. d is the number of experts
in the round.
Ntoburi et al. BMC Pediatrics 2010, 10:90
http://www.biomedcentral.com/1471-2431/10/90
Page 4 of 11
structure-based - 54/111(48.6%) for the international
panel and 43/93(46.2%) for the local panel. When a more
strict definition of acceptance and agreement (consensus
criterion 2) is imposed, the number of indicators
accepted reduces drastically for the local panel (from 93
to 38). There was a much smaller reduction for the inter-
national panel (from 111 to 104), reflecting the larger
final-round variability in opinions among the local
experts. The numbers of indicators accepted in each
domain are summarised in Table 2. The top five indica-
tors within each domain accepted by the International
panel (consensus criterion 1) and ranked by consensus
criterion 3 are listed in Table 3. The full list of indicators
is available in Additional file 2 on the journal website.
Figure 3 Spider plots showing the median scores for various attributes as given by the international panel. The first panel shows the
median scores for structure indicators while the second panel shows the scores for process indicators. Labels are used here and the
corresponding indicator is described in Additional file 2. The indicators were rated on a 9 point Likert-type scale ranging from ‘strongly
disagree’(1) to ‘strongly agree’(9). Note that the axis begins at five signifying that most indicators were rated highly.
Table 1 Changes between rounds in acceptance of indicators (n = 132 indicators)
International Panel Local panel
Accepted Equivocal/
uncertain
Rejected Accepted Equivocal/
uncertain
Rejected
Round 2/1
Criterion 1 110 22 0 98 34 0
Criterion 2 58 74 0 59 73 0
Final round
Criterion 1 111 21 0 93 39 0
Criterion 2 104 28 0 38 94 0
Only indicators rated by both panels are included here.
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Table 2 Acceptance of care indicators by domain*
International Panel Local panel
Domain Accepted Equivocal/
uncertain
Rejected Accepted Equivocal/
uncertain
Rejected
Structure:
Equipment & drugs (n = 52) 41 11 0 30 22 0
Organisation (n = 14) 13 1 0 13 1 0
Processes:
General (n = 7) 6 1 0 4 3 0
Cough/pneumonia/asthma (n = 15) 12 3 0 10 5 0
Fever/malaria/meningitis (n = 14) 11 3 0 9 5 0
Diarrhoea & dehydration (n = 11) 10 1 0 9 2 0
Malnutrition (n = 11) 10 1 0 10 1 0
Neonatal care (n = 8) 8 0 0 8 0 0
*using consensus criterion 1 and based on final round ratings. Only indicators rated by both panels included here.
Table 3 Top five indicators by domain†
Structure: drugs and equipment
1. The availability of intravenous fluids with physiological sodium concentrations (one or more of: Normal saline, Hartmann’s solution, or Ringer’s
Lactate).
2. The availability of Epinephrine (Adrenaline) for injection.
3. The availability of the locally recommended first line oral antimalarial in settings where there is malaria.
4. The availability of Gentamicin.
5. The availability of vaccines including Pentavalent vaccine or DTP or DTP-HepB, BCG polio and measles vaccine in the hospital.
Structure: organisation of care
1. The presence of a system to prioritize severely ill children and group them together for observation in the ward.
2. The presence of a triage system in the outpatients department.
3. The presence of an area in the outpatients section of the hospital that is dedicated to provision of routine and walk-in services for children under
5 years only.
4. Proportion of all admitted children with documentation providing evidence that they were reassessed at least daily (during working days) by a
doctor or clinical officer.
5. The availability of up to date hospital records describing paediatric admissions with diagnosis, age, sex and outcomes.
General care for severely ill children:
1. The proportion of children described as unable to feed/drink or with AVPU < V who are prescribed an appropriate fluid or feed regimen.
2. The proportion of children who have documentation that they were clinically assessed (wasting or oedema of Kwashiokor) or assessed with
MUAC or WHZ for severe malnutrition.
3. The proportion of admitted children with documentation of assessment for ‘danger signs’ - these include convulsions, cyanosis, grunting, acidotic
breathing, weak pulse, capillary refill, consciouness level (AVPU score) (in)ability to drink, neck stiffness or bulging fontanelle.
4. The proportion of Diazepam prescriptions for convulsions that are of the correct dose (iv or rectal doses according to national guidelines).
5. The proportion of prescriptions for injection Phenobarbitone that are the correct dose.
Cough/pneumoia/asthma:
1. The proportion of children with pneumonia prescribed antibiotics at correct doses (correct dose is defined as weight appropriate dose according
to WHO or local guidelines with a ± 20% range of acceptability).
2. The proportion of children prescribed oxygen correctly (including route device and flow rate).
3. The proportion of children with severe or very severe asthma correctly prescribed a steroid (including route of administration dose and
frequency).
4. The proportion of children with a diagnosis of pneumonia who are correctly classified as having pneumonia severe pneumonia or very severe
pneumonia (The correctness of classification must be based on documentation of appropriate supporting signs).
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Overall, there was very little evidence for a difference in
panel rankings for either the structure indicators (z = 0.23,
p = 0.81) or the process measures (z = 0.26, p = 0.80).
Based on consensus criterion 3, the results for both panels
suggest that almost all the structure indicators should be a
priority for reporting to the ministry of health while 36/66
(54.5%) and 35/66(53.0%) of the process measures were
considered both feasible currently and a priority for
reporting by the international and local panels respectively
(Table 4). Almost all process indicators were considered
feasible with improvements in record keeping. However,
acceptance rates reduce significantly when dispersion of
opinion is considered (consensus criterion 4). In particular
the local panel rated significantly fewer indicators
as accepted based on priority, feasibility currently or feasi-
bility with improvement when criteria include close
consensus.
Although much more demanding of information, more
than half of the international experts expressed a prefer-
ence for 6 out of the 7 composite indicators presented to
them. These composite indicators span multiple pro-
cesses in managing one case. Local experts preferred 5/7
Table 3: Top five indicators by domain?†? (Continued)
5. The proportion of children requiring oxygen (i.e. children with cyanosis or other signs of very severe pneumonia/asthma including grunting/head
nodding/inability to drink or breastfeed/AVPU < A) actually prescribed oxygen
Fever/malaria/meningitis:
1. The proportion of children with fever in a malaria endemic area who are investigated for malaria (with either a blood slide or rapid test).
2. The proportion of children with malaria prescribed treatment antimalarial that is appropriate to the clinician’s classification of severity and local
guidelines (correct drug choice dose and frequency)
3. The proportion of children with the presence or absence of fever recorded in their medical notes.
4. The proportion of children with a primary diagnosis of malaria in whom the diagnosis is supported by a positive blood slide/rapid test for malaria.
5. The proportion of children with a diagnosis of meningitis prescribed correct antibiotics (first line appropriate for context or second line if known
to have failed prior treatment) in correct doses.
Diarrhoea and dehydration:
1. The proportion of children with dehydration prescribed treatment (including right fluid type volume and rate) that is appropriate to their
classification (including shock/severe and some dehydration) and weight.
2. The proportion of children with bloody diarrhoea given correct antibiotic (as recommended by the national guidelines).
3. A composite indicator of the proportion of children assessed completely. This include skin turgor, sunken eyes level of consciousness, ability to
drink/breastfeed or sit, capillary refill, peripheral skin temperature and temperature gradient, presence of weak (absent) peripheral pulses, presence of
acidotic breathing, irritability, urine output, malnutrition
4. The proportion of diarrhoea cases prescribed Zinc (where this is national policy) at correct dose for age.
5. The proportion of children with diarrhoea who have documentation of whether or not there is blood in the stool.
Malnutrition:
1. The proportion of children in HIV endemic areas with a diagnosis of severe malnutrition who are tested for HIV as an inpatient.
2. The proportion of children with a diagnosis of severe malnutrition prescribed appropriate parenteral antibiotics.
3. The proportion of children with a diagnosis of severe malnutrition receiving Vitamin A on admission.
4. The proportion of children with a diagnosis of severe malnutrition and dehydration prescribed appropriate rehydration fluid (ReSoMal or other
low Sodium fluid e.g. half strength Darrows with potassium supplementation).
5. The proportion of children with a diagnosis of severe malnutrition prescribed the correct feed in the recommended volume and frequency.
Neonates:
1. The proportion of sick neonates with a diagnosis of neonatal sepsis prescribed the appropriate antibiotics (including correct choice of drug
correct dose for weight and age frequency and route of administration according to guideline).
2. The proportion of babies born in hospital to HIV+ mothers who receive PMTCT therapy in line with national policy.
3. The proportion of babies born in hospital whose mothers have their HIV status known before delivery.
4. The proportion of babies aged <14 days prescribed routine Vitamin K in countries where this is national policy.
5. The proportion of newborn babies who get eye prophylaxis (Tetracycline Eye Ointment).
†using consensus criterion 1 and ranked by consensus criterion 3. Based on final round ratings of the international panel.
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of these indicators (Additional file 3). However, only a
few experts in both panels preferred the proposed com-
posite indicator for children with pneumonia, perhaps
thinking it too complex and thus lacking feasibility. Based
on simple majority voting, the experts suggested that
most of the drugs or equipment needed to be in 2 or
more specific areas offering care to children or newborns
within the hospital to be considered available at a hospi-
tal level (for details see Additional file 4).
For drug doses, 14/15 of international experts and
7/11 local experts who answered the question agreed
that a correct dose should be within a range of ± 20% of
the dose for weight in the WHO or local guidelines.
Using Likert scales we investigated whether the ability
of laboratory to perform the following laboratory ser-
vices was linked to outcomes: blood glucose (bedside);
haemoglobin (or full blood count); microscopy or rapid
test for malaria (where endemic); HIV testing; blood
grouping and cross-matching; and CSF microscopy. All
were scored highly (median scores greater than 7)
though again opinions varied more for the local panel.
Both expert panels tended to rate ability to measure
bilirubin lowest (Additional file 3).
For the 132 indicators rated by both panels and based
on consensus criterion 1 and final round ratings, the
overall raw agreement was 85.9% (kappa 0.85, 95% CI
0.81-0.88). This indicates substantial agreement between
the two panels [35]. Agreement varied somewhat by
domain but was nonetheless relatively high in all of
them (Table 5).
Discussion
This study sought to assess the perceived value and
validity of a set of indicators of quality of inpatient care
proposed for children and newborns admitted to hospi-
tal in low-income countries. It used a transparent and
inexpensive method that combines scientific evidence
and expert opinion. Additionally, we intended to investi-
gate how well recommendations typically issued by
international organisations such as the WHO might be
accepted by local experts, as such views might influence
their local credibility. The Delphi technique proved use-
ful in both respects. The lack of an obligation to meet
face to face significantly improved the feasibility of the
study as cost was not a constraint on either the size or
composition of the international expert panel [36]. Most
of the indicators proposed were considered: reliable and
relevant to low-income settings; within the capabilities
of resource constrained health systems to improve; able
to identify areas urgently in need of attention and; to be
feasible targets of data collection.
However, one of our anticipated project outputs was
identification of a parsimonious set of indicators (about
20-30) that we felt might realistically form the basis of
routine and widespread reporting to ministries of health
in low-income countries. In this respect it can be argued
that the process failed, with support for a large number
of indicators of quality of care, making implementation
of routine, national quality assessment incorporating all
of these potentially more difficult. The demonstrated
support for a large number of indicators might be inter-
preted as an endorsement of the scope and content of
the original WHO assessment tool and, by extension, a
desire to ensure that any assessment tool for hospital
inpatient care should span the resources, assessment
tasks and management required to provide effective care
for multiple, important diseases. Alternatively it may
reflect in part the numerous indicators presented to the
experts. Presenting a large initial set of indicators was
meant to minimize the risk of missing potentially
important issues and prevent a small number of investi-
gators (SN, ME) imposing their priorities at the outset.
Interestingly some of the national panel, when prompted
to prioritise indicators for reporting to the ministry of
health, were more likely than members of the interna-
tional panel to ‘downgrade’ indicators (although only to
an uncertain status) producing a potentially shorter list
and resulting in less apparent consensus in their final
round.
It is reassuring that there were high levels of agree-
ment between the local and international panels. Worth
noting is the high agreement achieved on the sets of
Table 4 Indicators considered a priority or feasible‡
International Local Fisher’s
exact
Consensus criterion 3§
Structure
Priority 51/54(94.4) 40/43
(93.0)
1.00
Process
Priority 43/57(75.4) 36/50
(72.0)
0.83
Feasible currently 38/57(66.7) 43/50
(86.0)
0.02
Feasible with
improvements
52/57(91.2) 49/50
(98.0)
0.21
Structure
Priority 35/54(64.8) 14/43
(32.6)
0.001
Process
Priority 24/57(42.1) 4/50(8.0) < 0.001
Feasible currently 27/57(47.4) 5/50(10.0) < 0.001
Feasible with
improvements
43/57(75.4) 7/50(14.0) < 0.001
§ Consensus criterion 1 requires that indicators have a median score of seven
or more on the attribute. || Consensus criterion 2 requires that an indicator
has a median score of 7 or more on the attribute and in addition the IQR
should be less than 2. Only indicators rated by both panels included here.
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indicators for care of sick neonates and malnourished
children. This may have been influenced by increasing
recent appreciation globally of the high case fatality
rates in these groups. Within panels however, there was
somewhat more divergence (larger variance) around
structural elements of care perhaps reflecting different
experts’ experiences of resource environments or the
poor scientific evidence available supporting their con-
tribution to better outcomes.
Responses on the feasibility of data collection for
assessment of an indicator under current conditions in
low-income settings varied, suggesting many panellists
were concerned that assessment of many important pro-
cess indicators requiring data from routine review of
medical charts may not be possible currently. There was
however optimism that measures could be instituted to
improve quality of data. This concern is echoed more
generally internationally [37], supported by experience
nationally [38,39]. However, an unexpected finding was
that indicators for neonatal care were accorded generally
higher scores on feasibility. Our experience of working
in district hospitals in Kenya [7] and from published
data elsewhere [8] seem contrary to these views. It is
possible, therefore, that the views expressed by the
experts on feasibility are overoptimistic and unduly
influenced by their desire to promote certain indicators.
Before any indicators are widely adopted they should be
tested for feasibility and ability to detect significant
change in performance (sensitivity) [40]. We are in the
process of evaluating the feasibility of the accepted set
of indicators using data from 8 Kenyan district hospitals.
More generally, improving the quality of care within a
health system will need improvements in information
system.
As our goal was to develop a tool that might be routi-
nely used to provide quantitative measures of quality at
scale within the capacity of an existing health system,
our focus was case record review. However, there are
alternative methods of collecting data on the process of
care such as direct observation or use of vignettes.
Direct observation may influence care, and would be
time consuming and costly if a sample size sufficient
to produce a quantitative estimate is desired [41]. Vign-
ettes, perhaps best for assessing health worker knowl-
edge, have been used but similarly require organised
access to multiple health workers and so may be hard to
implement at scale in African settings [42].
There are potential limitations in our study that war-
rant mention. First, the results reported here represent
the opinions of only a few, non-randomly selected indi-
viduals. However, our international panel had members
with wide and long clinical and quality improvement
experience in low-income settings. The local panel con-
sisted largely of experts drawn from an academic refer-
ral centre. However, the local experts are influential,
frequently called upon by government to provide expert
technical advice and are responsible for training of
health workers. They thus represent an important con-
stituency in brokering the acceptance or rejection of
international recommendations at a country level.
Second, we did not grade or present the strength of
evidence linking indicators to outcomes in the question-
naires. This was in part due to the scale and scope of
the task with considerable implications on workload for
both the researchers and expert panellists. Moreover,
the indicators were derived from the practices or
resource implications of existing WHO recommenda-
tions for hospital care [28]. Third, our definition of
Table 5 Agreement between panels’ acceptance of care indicators at final round
Criterion 1 Criterion 2
Domain Raw agreement
(%)
Kappa statistic
(95% C1)¶
Raw agreement
(%)
Kappa statistic
(95% C1)¶
Structure:
Equipment & drugs (n = 52) 78.2 0.77(0.70-0.84) 60.3 0.56(0.47-0.64)
Organisation (n = 14) 90.5 0.90(0.77-0.98) 76.2 0.74(0.60-0.87)
All structure indicators (n = 66) 90.9 0.90(0.86-0.94) 53.5 0.54(0.47-0.60)
Processes:
General (n = 7) 81.0 0.80(0.61-0.95) 52.4 0.55(0.35-0.76)
Cough/pneumonia/asthma (n = 15) 82.2 0.81(0.67-0.93) 37.8 0.36(0.18-0.48)
Fever/malaria/meningitis (n = 14) 90.5 0.90(0.79-0.98) 57.1 0.57(0.43-0.72)
Diarrhoea & dehydration (n = 11) 93.9 0.94(0.81-1.00) 57.6 0.59(0.42-0.76)
Malnutrition (n = 11) ** 1 - 51.5 0.50(0.30-0.68)
Neonatal care (n = 8) ** 1 - 75.0 0.74(0.53-0.91)
All process indicators (n = 66) 80.8 0.80(0.73-0.86) 63.6 0.60(0.53-0.68)
All indicators (n = 132) 85.9 0.85(0.81-0.88) 58.6 0.57(0.51-0.62)
¶Based on final round ratings and indicators rated by both panels. Kappa 95% CI obtained from bootstrap; ** too few categories of disagreement to calculate
kappa and CI correctly.
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consensus, though based on published studies, remains
somewhat arbitrary [30,43]. Altering the definition of
consensus, for example by calculating mean scores
across attributes for each indicator, did not result in sig-
nificant change in those accepted by the predefined cri-
teria (data not shown). The post hoc analysis (consensus
criterion 2) may be useful if the intention is to reduce
the list of indicators. Fourth, the process did not involve
experts meeting face to face. While this reduced the
cost, many may argue that an opportunity for experts to
meet would have stimulated useful discussion on con-
tentious issues [31]. We did however encourage experts
to make comments which we then summarised and fed
back to the group through a moderator.
Methodologically, some valuable lessons were learnt.
First, Delphi studies are time consuming with an average
turnabout time between rounds of approximately 1.5
months for emailed questionnaires. Second, the method
of delivering the instructions may have an effect on the
results of the process. The local panel received instruc-
tions by word of mouth and were more likely to priori-
tise indicators in round 2 compared to the international
experts who were given written instructions. Finally,
there is scope for refining definitions of consensus by
allowing the participants to decide on an appropriate
definition instead of imposing one.
Conclusions
Measurement of the quality of care is a prerequisite for
determining whether quality of care is improving.
Although there remains significant challenges in defin-
ing such measures, this study represents the first
attempt at a transparent, consensus based, international
approach to identify indicators of quality hospital care
for children and newborns suitable for use in low-
income settings. For process based measures, feasibility
of data collection remains a concern and should be
further evaluated. This study, based on a transparent
process, helps formally define widely acceptable, quanti-
tative indicators and provides a platform for further
debate and continuing indicator development that
should include the review and updating of indicators as
priorities and technologies change and interventions to
improve quality of care are scaled up. Such reviews may
be more likely if a relatively inexpensive process such as
the one described here is used.
Additional material
Additional file 1: Characteristics of the experts. † This represents the
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be considered available at a hospital level.
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